Literature DB >> 1971838

Heterogeneous radiation and heat sensitivity in vitro of human melanoma xenograft lines established from different lesions in the same patient. Comparisons with the radiation and heat sensitivity of cells isolated from the donor patient's surgical specimens.

E K Rofstad1, N Zaffaroni, M E Hystad.   

Abstract

Human melanoma xenograft lines were established in athymic nude mice (BALB/c-nu/nu/BOM) from the primary tumour (OKL-PRI), a s.c. metastasis (OKL-SCM) and a lymph node metastasis (OKL-LNM) in the same patient. The three lines differed in growth rate, melanin content, and radiation and heat sensitivity in vitro. The OKL-PRI line grew more slowly than the OKL-SCM and OKL-LNM lines and was the only line that synthesized significant amounts of melanin. The D0 values were 0.96 +/- 0.07 Gy, 0.87 +/- 0.07 Gy and 1.52 +/- 0.09 Gy (X-rays); 143 +/- 21 min, 109 +/- 12 min and 195 +/- 40 min (heat, 42.5 degrees C); and 21.3 +/- 2.7 min, 15.3 +/- 1.7 min and 26.7 +/- 3.0 min (heat, 44.5 degrees C) for the OKL-PRI, OKL-SCM and OKL-LNM line, respectively. The ranking of the lines in treatment sensitivity was equal for radiation and heat. The radiation and heat sensitivities were similar to those for cells isolated directly from the surgical specimens of the donor patient. The lines were thus established from a single neoplastic disease without artificial cloning in vitro or in vivo, and the cellular radiation and heat sensitivity did not change during the establishment procedure, suggesting that they constitute a relevant experimental model system for studies of clonal tumour heterogeneity in response to radiation and hyperthermia treatments.

Entities:  

Mesh:

Year:  1990        PMID: 1971838     DOI: 10.1080/09553009014551231

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  5 in total

1.  The establishment of sublines with opposite chemosensitivity from a patient with pulmonary large cell carcinoma and the implementation of treatment based on tumor heterogeneity.

Authors:  S Kobayashi; S Okada; T Hasumi; N Sato; S Fujimura
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Long-term survival of a patient with stage IV pulmonary large cell carcinoma achieved by combined-modality therapy: report of a case.

Authors:  S Kobayashi; S Okada; T Hasumi; N Sato; S Fujimura
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

3.  Effect of melphalan and hyperthermia on p34cdc2 kinase activity in human melanoma cells.

Authors:  L Orlandi; N Zaffaroni; A Bearzatto; R Silvestrini
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

4.  Step-down heating of human melanoma xenografts: effects of the tumour microenvironment.

Authors:  E K Rofstad
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

5.  Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice.

Authors:  P Leuraud; L Taillandier; L Aguirre-Cruz; J Medioni; E Crinière; Y Marie; A M Dutrillaux; M Kujas; A Duprez; J-Y Delattre; M-F Poupon; M Sanson
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.